Form 4: Acadia Healthcare Director Vicky B. Gregg Sells 2,500 Shares

Director Vicky B. Gregg sold 2,500 shares of Acadia Healthcare Company, Inc. on March 4, 2024, at a weighted average price of $85.56 per share.

Summary

• On March 4, 2024, Vicky B. Gregg, a director of Acadia Healthcare Company, Inc., sold 2,500 shares of common stock.
• The sale was executed at a weighted average price of $85.56 per share, with individual transactions ranging from $85.50 to $85.62.
• Following the transaction, Gregg directly owns 26,851 shares of Acadia Healthcare Company, Inc.
• A power of attorney was executed on March 6, 2024, granting Brian Farley and Heather B. Dixon the authority to act on behalf of Vicky B. Gregg in matters related to SEC filings.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a director's stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This Form 4 filing is a routine disclosure of a transaction by a company insider and provides transparency to the market regarding the trading activities of Acadia Healthcare's director.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• Comparable companies like Universal Health Services (UHS) and HCA Healthcare (HCA) also have similar insider transaction reporting requirements.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
• The impact is likely minimal given the relatively small number of shares sold compared to the total outstanding shares.

Key Dates